• OPEN AN ACCOUNT
Indian Indices
Sensex
78,918.90 -1,097.00
( -1.37%)
Global Indices
Nasdaq
47,518.20 -457.55
(-0.95%)
Dow Jones
6,761.35 -90.36
(-1.32%)
Hang Seng
55,600.46 322.40
(0.58%)
Nikkei 225
10,286.75 -127.19
(-1.22%)
Forex
USD-INR
91.74 -0.39
(-0.42%)
EUR-INR
106.47 -0.59
(-0.55%)
GBP-INR
122.42 -0.61
(-0.50%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Ambey Laboratories Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
92828
INE0M3I01029
26.3962788
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AMBEY
12.17
57.38
EPS(TTM)
Face Value()
Div & Yield %
1.89
10
0
 

Gujarat Ambuja Exports commences commercial production of Sodium Gluconate at Hubli plant
Dec 19,2025
Gujarat Ambuja Exports has successfully commenced commercial production at India's first maize starch–based fermentation plant for the manufacturing of Sodium Gluconate, with an installed capacity of 30,000 TPA. The said facility is located at Hubli, Karnataka, and commercial production commenced with effect from 19 December 2025, at approximately 9:45 a.m.

The commencement of commercial operations at this facility represents a significant milestone in the Company's strategic expansion into maize fermentation–based products. The Company plans to further scale up capacity in this maize fermentation–based products by introducing additional products and aims to achieve an aggregate installed capacity of 1,20,000 TPA by the year 2028.